Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

$18M Seized from Massachusetts Compounding Pharmacy Accounts

By Pharmaceutical Processing | January 7, 2015

BOSTON (AP) — Authorities have seized over $18 million from the owners of a Massachusetts compounding pharmacy at the center of a 2012 meningitis outbreak that killed 64 people nationwide.

U.S. Attorney Carmen Ortiz said the funds were seized from 13 different financial institutions as a result of seizure warrants unsealed Tuesday.

About $16.8 million was frozen in accounts connected to husband-and-wife Douglas and Carla Conigliaro of Dedham. Carla Conigliaro was a majority shareholder at the now-shuttered New England Compounding Center in Framingham.

The Conigliaros have been charged with transferring assets following the outbreak, which was traced to tainted steroid injections made by the company.

According to Ortiz’s office, the Conigliaros transferred millions of dollars the same month that their company surrendered its pharmacy license and shortly before the company petitioned for bankruptcy. They also allegedly transferred millions more after a bankruptcy court issued two orders prohibiting them from transferring any assets.

Authorities say they seized another $1.5 million from accounts held by Barry Cadden, the company’s co-founder and a shareholder.

Cadden faces 25 counts of second-degree murder and is among 14 former employees charged in a federal racketeering conspiracy that authorities say is the largest U.S. criminal case ever brought over contaminated medicine.

New England Compounding Center employees are accused of using expired ingredients and failing to follow cleanliness standards, resulting in tainted steroid injections. More than 750 people in 20 states fell ill and 64 died. All 14 defendants have pleaded not guilty to the charges.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE